|
TET1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.121800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.816500E-02 |
| Normal-vs-Stage2 |
3.668300E-02 |
| Normal-vs-Stage3 |
5.663200E-03 |
| Normal-vs-Stage4 |
1.460080E-03 |
| Stage1-vs-Stage2 |
7.060000E-01 |
| Stage1-vs-Stage3 |
2.799000E-01 |
| Stage1-vs-Stage4 |
6.602200E-02 |
| Stage2-vs-Stage3 |
6.716800E-01 |
| Stage2-vs-Stage4 |
2.517000E-01 |
| Stage3-vs-Stage4 |
3.306400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.144300E-03 |
| Normal-vs-AfricanAmerican |
6.046200E-01 |
| Normal-vs-Asian |
1.409880E-02 |
| Caucasian-vs-AfricanAmerican |
2.063800E-01 |
| Caucasian-vs-Asian |
7.984600E-01 |
| AfricanAmerican-vs-Asian |
1.911850E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.214400E-02 |
| Normal-vs-Female |
5.140100E-03 |
| Male-vs-Female |
7.657200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.767500E-02 |
| Normal-vs-Age(41-60Yrs) |
4.863400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.485820E-02 |
| Normal-vs-Age(81-100Yrs) |
5.637400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.325600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.726400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.953600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.013800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.345200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.967200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.116800E-03 |
| Classical-VS-Follicular |
2.490200E-01 |
| Classical-VS-Other |
2.928000E-01 |
| Classical-VS-Normal |
1.066190E-02 |
| Tall-VS-Follicular |
9.001200E-04 |
| Tall-VS-Other |
4.904400E-01 |
| Tall-VS-Normal |
5.77789999999245E-05 |
| Follicular-VS-Other |
1.029800E-01 |
| Follicular-VS-Normal |
1.551830E-01 |
| Other-VS-Normal |
1.156490E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.009160E-01 |
| Normal-vs-N1 |
7.846600E-04 |
| N0-vs-N1 |
1.863960E-02 |
|
|
